{"id":"W2068045978","doi":"10.1038/leu.2013.152","title":"Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study","year":2013,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Calgary; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Onyx Pharmaceuticals","keywords":"Carfilzomib; Internal medicine; Cytogenetics; Oncology; Medicine; Refractory (planetary science); Multiple myeloma; Fluorescence in situ hybridization; Confidence interval; Population; Gastroenterology; Biology; Lenalidomide; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007595769,0.0002851828,0.0007166902,0.0002761848,0.0003247422,0.0005870865,0.0003150402,0.0006255106,0.000586196],"category_scores_gemma":[0.001002479,0.0002066344,0.0007025519,0.0004383489,0.0002835044,0.0004202344,0.0003345882,0.0006452605,0.0001416158],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006138456,"about_ca_system_score_gemma":0.0003980861,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001416319,"about_ca_topic_score_gemma":0.001619763,"domain_scores_codex":[0.999592,0.0001510076,0.00003259131,0.00008106652,0.00006508637,0.00007822008],"domain_scores_gemma":[0.9992642,0.0001148832,0.0002836287,0.00004885095,0.00003307335,0.000255339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01353956,0.0005490708,0.9751643,0.0000355392,0.0004317816,0.0005239428,0.0001544426,0.0005498623,0.0020493,0.00004465389,0.0002992263,0.006658263],"study_design_scores_gemma":[0.0009674234,0.005336962,0.9908292,0.000008452856,0.0002052711,0.0007974762,0.0001127716,0.0008224808,0.0003633598,0.00006390169,0.0004762919,0.00001635368],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994766,0.0002045259,0.00002601748,0.00003748348,0.000003846101,0.000009769489,0.0001374121,0.000001588238,0.000102755],"genre_scores_gemma":[0.9993342,0.00006495353,0.00002658584,0.00004397306,0.0000138536,0.00001302604,0.0004244689,9.07686e-7,0.00007819632],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001416319,"threshold_uncertainty_score":0.004453719,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0200916927116958,"score_gpt":0.2568875595864741,"score_spread":0.2367958668747783,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}